Sep 12 |
Oruka Therapeutics announces $200M private financing
|
Sep 12 |
Oruka Therapeutics Announces $200 Million Private Placement
|
Sep 12 |
Oruka Therapeutics Announces Accelerated Clinical Timelines and Upcoming Presentation at EADV Supporting ORKA-001’s Profile as a Potentially Best-in-Class Half-Life Extended Antibody Targeting IL-23p19
|
Sep 3 |
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
|
Aug 29 |
ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split
|
Aug 20 |
We're Not Very Worried About ARCA biopharma's (NASDAQ:ABIO) Cash Burn Rate
|
Aug 19 |
Top Midday Gainers
|
Aug 19 |
Estée Lauder, Palo Alto Networks And 3 Stocks To Watch Heading Into Monday
|
Aug 16 |
ARCA biopharma declares $1.59 dividend
|
Aug 16 |
ARCA biopharma Declares Special Dividend in Connection with the Proposed Merger with Oruka Therapeutics
|